References
Albani F, Riva R, Baruzzi A (1993) Clarithromycin-carbamazepine interaction: a case report. Epilepsia 34: 161–162
Periti P, Mazzei T, Mini E, Novelli A (1992) Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 23: 106–131
Ruff F, Chu SY, Sonders RC, Sennello LT (1990) Effect of multiple doses of clarithromycin (C) on the pharamcokinetics (Pks) of theophylline (T) (abstract 761). Program and Abstracts of the 30th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, October 23, Atlanta GA
Shapiro R, Venkataramanan R, Warty VS, Scantlebury VP, Rybka W, McCauley J, Fung JJ, Starzl TE (1993) FK 506 interaction with danazol. Lancet 341: 1344–1345
Venkataramanan R, Jain A, Warty VS, Abu-Elmagd K, Alessiani M, Lever J, Krajak A, Flowers J, Mehta S, Zuckerman S, Fung J, Todo S, Starzl TE (1991) Pharmacokinetics of FK 506 in transplant patients. Transplant Proc 23: 2736–2740
Vincent SH, Karanam BV, Painter SK, Chiu SHL (1992) In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. Arch Biochem Biophys 294: 454–460
Waites KB, Cassell GH, Canupp KC, Fernandes PB (1988) In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents Chemother 32: 1500–1502
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolter, K., Wagner, K., Philipp, T. et al. Interaction between FK 506 and clarithromycin in a renal transplant patient. Eur J Clin Pharmacol 47, 207–208 (1994). https://doi.org/10.1007/BF00194974
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00194974